Testing effectiveness (Phase 2)Study completedNCT02626364
What this trial is testing
Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
Who this might be right for
Recurrent/Refractory Glioblastoma
Arog Pharmaceuticals, Inc. 11